nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—epilepsy syndrome	0.288	1	CbGaD
Cefotetan—ALB—Oxcarbazepine—epilepsy syndrome	0.108	0.205	CbGbCtD
Cefotetan—ALB—Fosphenytoin—epilepsy syndrome	0.0948	0.179	CbGbCtD
Cefotetan—ALB—Clonazepam—epilepsy syndrome	0.0858	0.162	CbGbCtD
Cefotetan—ALB—Rufinamide—epilepsy syndrome	0.0699	0.132	CbGbCtD
Cefotetan—ALB—Phenytoin—epilepsy syndrome	0.0611	0.116	CbGbCtD
Cefotetan—ALB—Propofol—epilepsy syndrome	0.057	0.108	CbGbCtD
Cefotetan—ALB—Diazepam—epilepsy syndrome	0.0516	0.0976	CbGbCtD
Cefotetan—ALB—Transport of organic anions—SLCO1A2—epilepsy syndrome	0.00122	0.0776	CbGpPWpGaD
Cefotetan—Ceftriaxone—GLUL—epilepsy syndrome	0.00108	0.497	CrCbGaD
Cefotetan—ALB—Recycling of bile acids and salts—SLCO1A2—epilepsy syndrome	0.000906	0.0575	CbGpPWpGaD
Cefotetan—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A2—epilepsy syndrome	0.000599	0.038	CbGpPWpGaD
Cefotetan—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A3—epilepsy syndrome	0.000599	0.038	CbGpPWpGaD
Cefotetan—ALB—Bile acid and bile salt metabolism—SLCO1A2—epilepsy syndrome	0.000474	0.0301	CbGpPWpGaD
Cefotetan—ALB—Transport of vitamins, nucleosides, and related molecules—SLCO1A2—epilepsy syndrome	0.000454	0.0288	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—FOLR1—epilepsy syndrome	0.000432	0.0274	CbGpPWpGaD
Cefotetan—ALB—Bile acid and bile salt metabolism—HSD17B4—epilepsy syndrome	0.000417	0.0265	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.000403	0.0256	CbGpPWpGaD
Cefotetan—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—epilepsy syndrome	0.000353	0.0224	CbGpPWpGaD
Cefotetan—ALB—Transport of organic anions—AVP—epilepsy syndrome	0.000352	0.0223	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—LAMP2—epilepsy syndrome	0.000302	0.0191	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—LAMP2—epilepsy syndrome	0.000287	0.0182	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.00028	0.0177	CbGpPWpGaD
Cefotetan—Cefpiramide—ALB—epilepsy syndrome	0.000276	0.127	CrCbGaD
Cefotetan—Diarrhoea—Lacosamide—epilepsy syndrome	0.000263	0.00159	CcSEcCtD
Cefotetan—Rash—Phenobarbital—epilepsy syndrome	0.000262	0.00159	CcSEcCtD
Cefotetan—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000262	0.00159	CcSEcCtD
Cefotetan—Dermatitis—Phenobarbital—epilepsy syndrome	0.000262	0.00159	CcSEcCtD
Cefotetan—Leukopenia—Carbamazepine—epilepsy syndrome	0.000262	0.00159	CcSEcCtD
Cefotetan—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000261	0.00159	CcSEcCtD
Cefotetan—Vomiting—Rufinamide—epilepsy syndrome	0.00026	0.00158	CcSEcCtD
Cefotetan—Discomfort—Clonazepam—epilepsy syndrome	0.00026	0.00158	CcSEcCtD
Cefotetan—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000259	0.00157	CcSEcCtD
Cefotetan—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000258	0.00157	CcSEcCtD
Cefotetan—Discomfort—Phenytoin—epilepsy syndrome	0.000258	0.00156	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Pregabalin—epilepsy syndrome	0.000258	0.00156	CcSEcCtD
Cefotetan—Rash—Rufinamide—epilepsy syndrome	0.000258	0.00156	CcSEcCtD
Cefotetan—Dermatitis—Rufinamide—epilepsy syndrome	0.000257	0.00156	CcSEcCtD
Cefotetan—Discomfort—Oxcarbazepine—epilepsy syndrome	0.000256	0.00156	CcSEcCtD
Cefotetan—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000256	0.00155	CcSEcCtD
Cefotetan—Diarrhoea—Clobazam—epilepsy syndrome	0.000255	0.00155	CcSEcCtD
Cefotetan—Convulsion—Carbamazepine—epilepsy syndrome	0.000254	0.00154	CcSEcCtD
Cefotetan—Leukopenia—Lamotrigine—epilepsy syndrome	0.000253	0.00154	CcSEcCtD
Cefotetan—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000252	0.00153	CcSEcCtD
Cefotetan—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00025	0.00152	CcSEcCtD
Cefotetan—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000249	0.00151	CcSEcCtD
Cefotetan—Nausea—Phenobarbital—epilepsy syndrome	0.000247	0.0015	CcSEcCtD
Cefotetan—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000247	0.0015	CcSEcCtD
Cefotetan—Convulsion—Lamotrigine—epilepsy syndrome	0.000245	0.00149	CcSEcCtD
Cefotetan—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000245	0.00149	CcSEcCtD
Cefotetan—Urticaria—Propofol—epilepsy syndrome	0.000245	0.00149	CcSEcCtD
Cefotetan—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Vomiting—Lacosamide—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Abdominal pain—Propofol—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Body temperature increased—Propofol—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000244	0.00148	CcSEcCtD
Cefotetan—Nausea—Rufinamide—epilepsy syndrome	0.000243	0.00147	CcSEcCtD
Cefotetan—Rash—Lacosamide—epilepsy syndrome	0.000242	0.00147	CcSEcCtD
Cefotetan—Dermatitis—Lacosamide—epilepsy syndrome	0.000242	0.00147	CcSEcCtD
Cefotetan—Cefonicid—ALB—epilepsy syndrome	0.00024	0.11	CrCbGaD
Cefotetan—Urticaria—Midazolam—epilepsy syndrome	0.00024	0.00145	CcSEcCtD
Cefotetan—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000239	0.00145	CcSEcCtD
Cefotetan—Discomfort—Lamotrigine—epilepsy syndrome	0.000238	0.00144	CcSEcCtD
Cefotetan—Vomiting—Clobazam—epilepsy syndrome	0.000237	0.00144	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Gabapentin—epilepsy syndrome	0.000236	0.00143	CcSEcCtD
Cefotetan—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000235	0.00143	CcSEcCtD
Cefotetan—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000235	0.00143	CcSEcCtD
Cefotetan—Rash—Clobazam—epilepsy syndrome	0.000235	0.00142	CcSEcCtD
Cefotetan—Dermatitis—Clobazam—epilepsy syndrome	0.000235	0.00142	CcSEcCtD
Cefotetan—Haemoglobin—Pregabalin—epilepsy syndrome	0.000235	0.00142	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Topiramate—epilepsy syndrome	0.000234	0.00142	CcSEcCtD
Cefotetan—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000234	0.00142	CcSEcCtD
Cefotetan—Haemorrhage—Pregabalin—epilepsy syndrome	0.000233	0.00142	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000229	0.00139	CcSEcCtD
Cefotetan—Urticaria—Fosphenytoin—epilepsy syndrome	0.000228	0.00139	CcSEcCtD
Cefotetan—Nausea—Lacosamide—epilepsy syndrome	0.000228	0.00138	CcSEcCtD
Cefotetan—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000227	0.00138	CcSEcCtD
Cefotetan—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000227	0.00138	CcSEcCtD
Cefotetan—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000226	0.00137	CcSEcCtD
Cefotetan—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000226	0.00137	CcSEcCtD
Cefotetan—Eosinophilia—Topiramate—epilepsy syndrome	0.000223	0.00135	CcSEcCtD
Cefotetan—Urticaria—Vigabatrin—epilepsy syndrome	0.000223	0.00135	CcSEcCtD
Cefotetan—Hypersensitivity—Midazolam—epilepsy syndrome	0.000222	0.00135	CcSEcCtD
Cefotetan—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000221	0.00134	CcSEcCtD
Cefotetan—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000221	0.00134	CcSEcCtD
Cefotetan—Nausea—Clobazam—epilepsy syndrome	0.000221	0.00134	CcSEcCtD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000221	0.014	CbGpPWpGaD
Cefotetan—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000221	0.00134	CcSEcCtD
Cefotetan—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000219	0.00133	CcSEcCtD
Cefotetan—Urticaria—Diazepam—epilepsy syndrome	0.000219	0.00133	CcSEcCtD
Cefotetan—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000218	0.00133	CcSEcCtD
Cefotetan—Pruritus—Propofol—epilepsy syndrome	0.000218	0.00132	CcSEcCtD
Cefotetan—Abdominal pain—Diazepam—epilepsy syndrome	0.000218	0.00132	CcSEcCtD
Cefotetan—Haemorrhage—Gabapentin—epilepsy syndrome	0.000214	0.0013	CcSEcCtD
Cefotetan—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000214	0.0013	CcSEcCtD
Cefotetan—Pancytopenia—Topiramate—epilepsy syndrome	0.000214	0.0013	CcSEcCtD
Cefotetan—Pruritus—Midazolam—epilepsy syndrome	0.000213	0.0013	CcSEcCtD
Cefotetan—ALB—HDL-mediated lipid transport—APOE—epilepsy syndrome	0.000212	0.0135	CbGpPWpGaD
Cefotetan—Urticaria—Felbamate—epilepsy syndrome	0.000212	0.00129	CcSEcCtD
Cefotetan—Cefmetazole—ALB—epilepsy syndrome	0.000211	0.097	CrCbGaD
Cefotetan—Body temperature increased—Felbamate—epilepsy syndrome	0.000211	0.00128	CcSEcCtD
Cefotetan—Abdominal pain—Felbamate—epilepsy syndrome	0.000211	0.00128	CcSEcCtD
Cefotetan—Vomiting—Acetazolamide—epilepsy syndrome	0.000211	0.00128	CcSEcCtD
Cefotetan—Diarrhoea—Propofol—epilepsy syndrome	0.000211	0.00128	CcSEcCtD
Cefotetan—Pruritus—Levetiracetam—epilepsy syndrome	0.000211	0.00128	CcSEcCtD
Cefotetan—Neutropenia—Topiramate—epilepsy syndrome	0.00021	0.00128	CcSEcCtD
Cefotetan—Urticaria—Zonisamide—epilepsy syndrome	0.000208	0.00126	CcSEcCtD
Cefotetan—Body temperature increased—Zonisamide—epilepsy syndrome	0.000207	0.00125	CcSEcCtD
Cefotetan—Abdominal pain—Zonisamide—epilepsy syndrome	0.000207	0.00125	CcSEcCtD
Cefotetan—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000206	0.00125	CcSEcCtD
Cefotetan—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000206	0.00125	CcSEcCtD
Cefotetan—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000204	0.00124	CcSEcCtD
Cefotetan—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000203	0.00124	CcSEcCtD
Cefotetan—Pruritus—Fosphenytoin—epilepsy syndrome	0.000203	0.00123	CcSEcCtD
Cefotetan—Hypersensitivity—Diazepam—epilepsy syndrome	0.000203	0.00123	CcSEcCtD
Cefotetan—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000202	0.00123	CcSEcCtD
Cefotetan—Leukopenia—Valproic Acid—epilepsy syndrome	0.000201	0.00122	CcSEcCtD
Cefotetan—Urticaria—Clonazepam—epilepsy syndrome	0.0002	0.00121	CcSEcCtD
Cefotetan—Body temperature increased—Clonazepam—epilepsy syndrome	0.000199	0.00121	CcSEcCtD
Cefotetan—Abdominal pain—Clonazepam—epilepsy syndrome	0.000199	0.00121	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000199	0.00121	CcSEcCtD
Cefotetan—Urticaria—Phenytoin—epilepsy syndrome	0.000199	0.00121	CcSEcCtD
Cefotetan—Pruritus—Vigabatrin—epilepsy syndrome	0.000198	0.0012	CcSEcCtD
Cefotetan—Body temperature increased—Phenytoin—epilepsy syndrome	0.000198	0.0012	CcSEcCtD
Cefotetan—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000198	0.0012	CcSEcCtD
Cefotetan—Nausea—Acetazolamide—epilepsy syndrome	0.000197	0.0012	CcSEcCtD
Cefotetan—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000197	0.00119	CcSEcCtD
Cefotetan—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000197	0.00119	CcSEcCtD
Cefotetan—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000197	0.00119	CcSEcCtD
Cefotetan—Vomiting—Propofol—epilepsy syndrome	0.000196	0.00119	CcSEcCtD
Cefotetan—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000195	0.00119	CcSEcCtD
Cefotetan—Pruritus—Diazepam—epilepsy syndrome	0.000195	0.00118	CcSEcCtD
Cefotetan—Rash—Propofol—epilepsy syndrome	0.000194	0.00118	CcSEcCtD
Cefotetan—Dermatitis—Propofol—epilepsy syndrome	0.000194	0.00118	CcSEcCtD
Cefotetan—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000193	0.00117	CcSEcCtD
Cefotetan—Vomiting—Midazolam—epilepsy syndrome	0.000192	0.00116	CcSEcCtD
Cefotetan—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000192	0.00116	CcSEcCtD
Cefotetan—Rash—Midazolam—epilepsy syndrome	0.00019	0.00115	CcSEcCtD
Cefotetan—Dermatitis—Midazolam—epilepsy syndrome	0.00019	0.00115	CcSEcCtD
Cefotetan—Urticaria—Carbamazepine—epilepsy syndrome	0.00019	0.00115	CcSEcCtD
Cefotetan—Vomiting—Levetiracetam—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Discomfort—Valproic Acid—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Pruritus—Felbamate—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Diarrhoea—Diazepam—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000189	0.00115	CcSEcCtD
Cefotetan—Rash—Levetiracetam—epilepsy syndrome	0.000188	0.00114	CcSEcCtD
Cefotetan—Dermatitis—Levetiracetam—epilepsy syndrome	0.000188	0.00114	CcSEcCtD
Cefotetan—Agranulocytosis—Topiramate—epilepsy syndrome	0.000187	0.00114	CcSEcCtD
Cefotetan—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000186	0.00113	CcSEcCtD
Cefotetan—Pruritus—Zonisamide—epilepsy syndrome	0.000185	0.00112	CcSEcCtD
Cefotetan—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000184	0.00112	CcSEcCtD
Cefotetan—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Urticaria—Lamotrigine—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Nausea—Propofol—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Vomiting—Fosphenytoin—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Diarrhoea—Felbamate—epilepsy syndrome	0.000183	0.00111	CcSEcCtD
Cefotetan—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000182	0.00111	CcSEcCtD
Cefotetan—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000182	0.00111	CcSEcCtD
Cefotetan—Leukopenia—Pregabalin—epilepsy syndrome	0.000182	0.0011	CcSEcCtD
Cefotetan—Rash—Fosphenytoin—epilepsy syndrome	0.000181	0.0011	CcSEcCtD
Cefotetan—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000181	0.0011	CcSEcCtD
Cefotetan—Haemoglobin—Topiramate—epilepsy syndrome	0.000181	0.0011	CcSEcCtD
Cefotetan—Haemorrhage—Topiramate—epilepsy syndrome	0.00018	0.00109	CcSEcCtD
Cefotetan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.00018	0.00109	CcSEcCtD
Cefotetan—Nausea—Midazolam—epilepsy syndrome	0.000179	0.00109	CcSEcCtD
Cefotetan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000179	0.00109	CcSEcCtD
Cefotetan—Pruritus—Clonazepam—epilepsy syndrome	0.000178	0.00108	CcSEcCtD
Cefotetan—Vomiting—Vigabatrin—epilepsy syndrome	0.000178	0.00108	CcSEcCtD
Cefotetan—Pruritus—Phenytoin—epilepsy syndrome	0.000177	0.00107	CcSEcCtD
Cefotetan—Nausea—Levetiracetam—epilepsy syndrome	0.000177	0.00107	CcSEcCtD
Cefotetan—Rash—Vigabatrin—epilepsy syndrome	0.000177	0.00107	CcSEcCtD
Cefotetan—Dermatitis—Vigabatrin—epilepsy syndrome	0.000177	0.00107	CcSEcCtD
Cefotetan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000176	0.00107	CcSEcCtD
Cefotetan—Convulsion—Pregabalin—epilepsy syndrome	0.000176	0.00107	CcSEcCtD
Cefotetan—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000176	0.00107	CcSEcCtD
Cefotetan—Vomiting—Diazepam—epilepsy syndrome	0.000175	0.00106	CcSEcCtD
Cefotetan—Rash—Diazepam—epilepsy syndrome	0.000174	0.00106	CcSEcCtD
Cefotetan—Dermatitis—Diazepam—epilepsy syndrome	0.000174	0.00105	CcSEcCtD
Cefotetan—Diarrhoea—Clonazepam—epilepsy syndrome	0.000172	0.00105	CcSEcCtD
Cefotetan—Diarrhoea—Phenytoin—epilepsy syndrome	0.000171	0.00104	CcSEcCtD
Cefotetan—Discomfort—Pregabalin—epilepsy syndrome	0.000171	0.00104	CcSEcCtD
Cefotetan—Nausea—Fosphenytoin—epilepsy syndrome	0.000171	0.00104	CcSEcCtD
Cefotetan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00017	0.00103	CcSEcCtD
Cefotetan—Erythema multiforme—Topiramate—epilepsy syndrome	0.00017	0.00103	CcSEcCtD
Cefotetan—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00017	0.00103	CcSEcCtD
Cefotetan—Vomiting—Felbamate—epilepsy syndrome	0.00017	0.00103	CcSEcCtD
Cefotetan—Pruritus—Carbamazepine—epilepsy syndrome	0.000169	0.00103	CcSEcCtD
Cefotetan—Rash—Felbamate—epilepsy syndrome	0.000168	0.00102	CcSEcCtD
Cefotetan—Dermatitis—Felbamate—epilepsy syndrome	0.000168	0.00102	CcSEcCtD
Cefotetan—Leukopenia—Gabapentin—epilepsy syndrome	0.000167	0.00101	CcSEcCtD
Cefotetan—Nausea—Vigabatrin—epilepsy syndrome	0.000166	0.00101	CcSEcCtD
Cefotetan—Vomiting—Zonisamide—epilepsy syndrome	0.000166	0.00101	CcSEcCtD
Cefotetan—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000166	0.00101	CcSEcCtD
Cefotetan—Rash—Zonisamide—epilepsy syndrome	0.000165	0.001	CcSEcCtD
Cefotetan—Dermatitis—Zonisamide—epilepsy syndrome	0.000165	0.000999	CcSEcCtD
Cefotetan—Nausea—Diazepam—epilepsy syndrome	0.000164	0.000994	CcSEcCtD
Cefotetan—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000163	0.000992	CcSEcCtD
Cefotetan—Pruritus—Lamotrigine—epilepsy syndrome	0.000163	0.000991	CcSEcCtD
Cefotetan—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000162	0.000985	CcSEcCtD
Cefotetan—Convulsion—Gabapentin—epilepsy syndrome	0.000161	0.00098	CcSEcCtD
Cefotetan—Vomiting—Clonazepam—epilepsy syndrome	0.00016	0.000972	CcSEcCtD
Cefotetan—Vomiting—Phenytoin—epilepsy syndrome	0.000159	0.000965	CcSEcCtD
Cefotetan—Rash—Clonazepam—epilepsy syndrome	0.000159	0.000964	CcSEcCtD
Cefotetan—Dermatitis—Clonazepam—epilepsy syndrome	0.000159	0.000963	CcSEcCtD
Cefotetan—Nausea—Felbamate—epilepsy syndrome	0.000159	0.000963	CcSEcCtD
Cefotetan—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000158	0.00096	CcSEcCtD
Cefotetan—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000158	0.000958	CcSEcCtD
Cefotetan—Rash—Phenytoin—epilepsy syndrome	0.000158	0.000957	CcSEcCtD
Cefotetan—Dermatitis—Phenytoin—epilepsy syndrome	0.000158	0.000957	CcSEcCtD
Cefotetan—Rash—Oxcarbazepine—epilepsy syndrome	0.000157	0.000952	CcSEcCtD
Cefotetan—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000157	0.000951	CcSEcCtD
Cefotetan—Discomfort—Gabapentin—epilepsy syndrome	0.000157	0.000951	CcSEcCtD
Cefotetan—Nausea—Zonisamide—epilepsy syndrome	0.000155	0.000942	CcSEcCtD
Cefotetan—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000152	0.000923	CcSEcCtD
Cefotetan—Vomiting—Carbamazepine—epilepsy syndrome	0.000152	0.000922	CcSEcCtD
Cefotetan—ALB—Platelet degranulation—FLNA—epilepsy syndrome	0.000152	0.00961	CbGpPWpGaD
Cefotetan—Rash—Carbamazepine—epilepsy syndrome	0.000151	0.000914	CcSEcCtD
Cefotetan—Dermatitis—Carbamazepine—epilepsy syndrome	0.00015	0.000913	CcSEcCtD
Cefotetan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00015	0.00091	CcSEcCtD
Cefotetan—Nausea—Clonazepam—epilepsy syndrome	0.00015	0.000908	CcSEcCtD
Cefotetan—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000149	0.000903	CcSEcCtD
Cefotetan—Nausea—Phenytoin—epilepsy syndrome	0.000149	0.000902	CcSEcCtD
Cefotetan—Nausea—Oxcarbazepine—epilepsy syndrome	0.000148	0.000897	CcSEcCtD
Cefotetan—Vomiting—Lamotrigine—epilepsy syndrome	0.000147	0.000891	CcSEcCtD
Cefotetan—Urticaria—Valproic Acid—epilepsy syndrome	0.000146	0.000884	CcSEcCtD
Cefotetan—Rash—Lamotrigine—epilepsy syndrome	0.000146	0.000883	CcSEcCtD
Cefotetan—Dermatitis—Lamotrigine—epilepsy syndrome	0.000145	0.000882	CcSEcCtD
Cefotetan—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000145	0.00088	CcSEcCtD
Cefotetan—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000145	0.00088	CcSEcCtD
Cefotetan—ALB—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.000145	0.00917	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—FLNA—epilepsy syndrome	0.000144	0.00916	CbGpPWpGaD
Cefotetan—Nausea—Carbamazepine—epilepsy syndrome	0.000142	0.000861	CcSEcCtD
Cefotetan—Cefoperazone—ALB—epilepsy syndrome	0.000142	0.065	CrCbGaD
Cefotetan—Leukopenia—Topiramate—epilepsy syndrome	0.00014	0.000851	CcSEcCtD
Cefotetan—Nausea—Lamotrigine—epilepsy syndrome	0.000137	0.000832	CcSEcCtD
Cefotetan—Convulsion—Topiramate—epilepsy syndrome	0.000136	0.000824	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000136	0.000823	CcSEcCtD
Cefotetan—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000135	0.00082	CcSEcCtD
Cefotetan—ALB—Platelet activation, signaling and aggregation—LAMP2—epilepsy syndrome	0.000134	0.00849	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—PLAT—epilepsy syndrome	0.000133	0.00842	CbGpPWpGaD
Cefotetan—Discomfort—Topiramate—epilepsy syndrome	0.000132	0.0008	CcSEcCtD
Cefotetan—Urticaria—Pregabalin—epilepsy syndrome	0.000132	0.000799	CcSEcCtD
Cefotetan—Body temperature increased—Pregabalin—epilepsy syndrome	0.000131	0.000796	CcSEcCtD
Cefotetan—Abdominal pain—Pregabalin—epilepsy syndrome	0.000131	0.000796	CcSEcCtD
Cefotetan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—epilepsy syndrome	0.000131	0.00828	CbGpPWpGaD
Cefotetan—Pruritus—Valproic Acid—epilepsy syndrome	0.00013	0.000788	CcSEcCtD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000129	0.00815	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000129	0.00815	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000129	0.00815	CbGpPWpGaD
Cefotetan—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000125	0.000762	CcSEcCtD
Cefotetan—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000125	0.00076	CcSEcCtD
Cefotetan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000124	0.000755	CcSEcCtD
Cefotetan—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000122	0.000741	CcSEcCtD
Cefotetan—ALB—Lipoprotein metabolism—APOE—epilepsy syndrome	0.000122	0.00774	CbGpPWpGaD
Cefotetan—Urticaria—Gabapentin—epilepsy syndrome	0.000121	0.000733	CcSEcCtD
Cefotetan—Abdominal pain—Gabapentin—epilepsy syndrome	0.00012	0.000729	CcSEcCtD
Cefotetan—Body temperature increased—Gabapentin—epilepsy syndrome	0.00012	0.000729	CcSEcCtD
Cefotetan—ALB—Platelet degranulation—PPIA—epilepsy syndrome	0.000119	0.00756	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000118	0.00746	CbGpPWpGaD
Cefotetan—Pruritus—Pregabalin—epilepsy syndrome	0.000117	0.000712	CcSEcCtD
Cefotetan—Vomiting—Valproic Acid—epilepsy syndrome	0.000117	0.000708	CcSEcCtD
Cefotetan—Cefazolin—ALB—epilepsy syndrome	0.000116	0.0534	CrCbGaD
Cefotetan—Rash—Valproic Acid—epilepsy syndrome	0.000116	0.000702	CcSEcCtD
Cefotetan—Dermatitis—Valproic Acid—epilepsy syndrome	0.000116	0.000701	CcSEcCtD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PPIA—epilepsy syndrome	0.000114	0.0072	CbGpPWpGaD
Cefotetan—Diarrhoea—Pregabalin—epilepsy syndrome	0.000113	0.000689	CcSEcCtD
Cefotetan—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000112	0.00068	CcSEcCtD
Cefotetan—Ceftriaxone—ALB—epilepsy syndrome	0.00011	0.0506	CrCbGaD
Cefotetan—Nausea—Valproic Acid—epilepsy syndrome	0.000109	0.000661	CcSEcCtD
Cefotetan—ALB—Folate Metabolism—PLAT—epilepsy syndrome	0.000108	0.00685	CbGpPWpGaD
Cefotetan—Pruritus—Gabapentin—epilepsy syndrome	0.000108	0.000653	CcSEcCtD
Cefotetan—Vomiting—Pregabalin—epilepsy syndrome	0.000105	0.00064	CcSEcCtD
Cefotetan—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000105	0.000635	CcSEcCtD
Cefotetan—Rash—Pregabalin—epilepsy syndrome	0.000105	0.000635	CcSEcCtD
Cefotetan—Dermatitis—Pregabalin—epilepsy syndrome	0.000104	0.000634	CcSEcCtD
Cefotetan—Diarrhoea—Gabapentin—epilepsy syndrome	0.000104	0.000631	CcSEcCtD
Cefotetan—Urticaria—Topiramate—epilepsy syndrome	0.000102	0.000617	CcSEcCtD
Cefotetan—Abdominal pain—Topiramate—epilepsy syndrome	0.000101	0.000614	CcSEcCtD
Cefotetan—Body temperature increased—Topiramate—epilepsy syndrome	0.000101	0.000614	CcSEcCtD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—epilepsy syndrome	0.000101	0.00641	CbGpPWpGaD
Cefotetan—Nausea—Pregabalin—epilepsy syndrome	9.85e-05	0.000598	CcSEcCtD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	9.74e-05	0.00618	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	9.74e-05	0.00618	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	9.74e-05	0.00618	CbGpPWpGaD
Cefotetan—Vomiting—Gabapentin—epilepsy syndrome	9.67e-05	0.000587	CcSEcCtD
Cefotetan—Rash—Gabapentin—epilepsy syndrome	9.59e-05	0.000582	CcSEcCtD
Cefotetan—Dermatitis—Gabapentin—epilepsy syndrome	9.58e-05	0.000581	CcSEcCtD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—epilepsy syndrome	9.5e-05	0.00603	CbGpPWpGaD
Cefotetan—Hypersensitivity—Topiramate—epilepsy syndrome	9.42e-05	0.000572	CcSEcCtD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	9.29e-05	0.00589	CbGpPWpGaD
Cefotetan—Pruritus—Topiramate—epilepsy syndrome	9.05e-05	0.000549	CcSEcCtD
Cefotetan—Nausea—Gabapentin—epilepsy syndrome	9.03e-05	0.000548	CcSEcCtD
Cefotetan—Diarrhoea—Topiramate—epilepsy syndrome	8.75e-05	0.000531	CcSEcCtD
Cefotetan—ALB—Selenium Micronutrient Network—PLAT—epilepsy syndrome	8.58e-05	0.00544	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—DOCK7—epilepsy syndrome	8.46e-05	0.00537	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CAT—epilepsy syndrome	8.36e-05	0.0053	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CRP—epilepsy syndrome	8.16e-05	0.00517	CbGpPWpGaD
Cefotetan—Vomiting—Topiramate—epilepsy syndrome	8.13e-05	0.000494	CcSEcCtD
Cefotetan—ALB—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	8.11e-05	0.00514	CbGpPWpGaD
Cefotetan—Rash—Topiramate—epilepsy syndrome	8.06e-05	0.000489	CcSEcCtD
Cefotetan—Dermatitis—Topiramate—epilepsy syndrome	8.06e-05	0.000489	CcSEcCtD
Cefotetan—ALB—Vitamin B12 Metabolism—APOE—epilepsy syndrome	7.98e-05	0.00506	CbGpPWpGaD
Cefotetan—Nausea—Topiramate—epilepsy syndrome	7.6e-05	0.000461	CcSEcCtD
Cefotetan—ALB—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	7.57e-05	0.00481	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—GPX1—epilepsy syndrome	7.56e-05	0.0048	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	7.38e-05	0.00468	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	7.38e-05	0.00468	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	7.33e-05	0.00465	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	7.33e-05	0.00465	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—LAMP2—epilepsy syndrome	6.9e-05	0.00438	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.87e-05	0.00436	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.87e-05	0.00436	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	6.75e-05	0.00428	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	6.72e-05	0.00426	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	6.71e-05	0.00426	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.64e-05	0.00421	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CRP—epilepsy syndrome	6.64e-05	0.00421	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	6.53e-05	0.00414	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	6.53e-05	0.00414	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	6.53e-05	0.00414	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	6.28e-05	0.00398	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	6e-05	0.00381	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.97e-05	0.00379	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SLC8A2—epilepsy syndrome	5.72e-05	0.00363	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	5.63e-05	0.00357	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.53e-05	0.00351	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CCL2—epilepsy syndrome	5.46e-05	0.00346	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SLC8A3—epilepsy syndrome	5.45e-05	0.00346	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	5.34e-05	0.00339	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	5.29e-05	0.00335	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	5.27e-05	0.00334	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	5.22e-05	0.00331	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.21e-05	0.0033	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	5.09e-05	0.00323	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	5e-05	0.00317	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.95e-05	0.00314	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.95e-05	0.00314	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.95e-05	0.00314	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.76e-05	0.00302	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	4.76e-05	0.00302	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.72e-05	0.003	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.72e-05	0.003	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.58e-05	0.00291	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—RELA—epilepsy syndrome	4.58e-05	0.00291	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	4.34e-05	0.00275	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.16e-05	0.00264	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL1B—epilepsy syndrome	4.14e-05	0.00263	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	4.12e-05	0.00262	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CA13—epilepsy syndrome	4.04e-05	0.00256	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.85e-05	0.00244	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.75e-05	0.00238	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.75e-05	0.00238	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.69e-05	0.00234	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TEK—epilepsy syndrome	3.68e-05	0.00234	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.64e-05	0.00231	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.61e-05	0.00229	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.58e-05	0.00227	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	3.53e-05	0.00224	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FLNA—epilepsy syndrome	3.46e-05	0.0022	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.44e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.43e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.43e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.43e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.43e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3.3e-05	0.00209	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.29e-05	0.00209	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KCNMA1—epilepsy syndrome	3.28e-05	0.00208	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.25e-05	0.00206	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SLC8A1—epilepsy syndrome	3.24e-05	0.00206	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.19e-05	0.00202	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	3.09e-05	0.00196	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PDXK—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CERS1—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GLUD1—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Metabolism—L2HGDH—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADK—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FAR1—epilepsy syndrome	3.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.04e-05	0.00193	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	3.01e-05	0.00191	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—epilepsy syndrome	3e-05	0.00191	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3e-05	0.0019	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.94e-05	0.00186	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.92e-05	0.00185	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.86e-05	0.00182	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.82e-05	0.00179	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.81e-05	0.00178	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.8e-05	0.00178	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PNPO—epilepsy syndrome	2.8e-05	0.00177	CbGpPWpGaD
Cefotetan—ALB—Metabolism—EPM2A—epilepsy syndrome	2.8e-05	0.00177	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.8e-05	0.00177	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GAMT—epilepsy syndrome	2.8e-05	0.00177	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PPIA—epilepsy syndrome	2.73e-05	0.00173	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.71e-05	0.00172	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.71e-05	0.00172	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CA4—epilepsy syndrome	2.6e-05	0.00165	CbGpPWpGaD
Cefotetan—ALB—Metabolism—QDPR—epilepsy syndrome	2.6e-05	0.00165	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.6e-05	0.00165	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.49e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Metabolism—COX3—epilepsy syndrome	2.45e-05	0.00155	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.42e-05	0.00153	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.41e-05	0.00153	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.39e-05	0.00151	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.33e-05	0.00148	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PFKL—epilepsy syndrome	2.32e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Metabolism—KCNB1—epilepsy syndrome	2.32e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.32e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.32e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.32e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.27e-05	0.00144	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.25e-05	0.00143	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.21e-05	0.0014	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.15e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ADRA2A—epilepsy syndrome	2.12e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NEU1—epilepsy syndrome	2.12e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ATIC—epilepsy syndrome	2.12e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UPB1—epilepsy syndrome	2.12e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAT—epilepsy syndrome	2.12e-05	0.00134	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSD17B4—epilepsy syndrome	2.04e-05	0.00129	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS1—epilepsy syndrome	1.99e-05	0.00126	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GBE1—epilepsy syndrome	1.97e-05	0.00125	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.97e-05	0.00125	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.93e-05	0.00122	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT3—epilepsy syndrome	1.86e-05	0.00118	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ASAH1—epilepsy syndrome	1.85e-05	0.00118	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.84e-05	0.00117	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.83e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Metabolism—STXBP1—epilepsy syndrome	1.8e-05	0.00114	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NT5E—epilepsy syndrome	1.76e-05	0.00111	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALAD—epilepsy syndrome	1.76e-05	0.00111	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.75e-05	0.00111	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CDC42—epilepsy syndrome	1.7e-05	0.00108	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.68e-05	0.00106	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.68e-05	0.00106	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.64e-05	0.00104	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADSL—epilepsy syndrome	1.61e-05	0.00102	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GLUL—epilepsy syndrome	1.58e-05	0.001	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.55e-05	0.000981	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FYN—epilepsy syndrome	1.51e-05	0.00096	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.45e-05	0.000923	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.45e-05	0.000918	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.44e-05	0.000912	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.42e-05	0.000904	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AQP1—epilepsy syndrome	1.4e-05	0.000891	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.38e-05	0.000875	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.37e-05	0.000868	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.35e-05	0.000856	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.33e-05	0.000846	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAU—epilepsy syndrome	1.29e-05	0.000819	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CHRM3—epilepsy syndrome	1.27e-05	0.000806	CbGpPWpGaD
Cefotetan—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.27e-05	0.000806	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.2e-05	0.000762	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS2—epilepsy syndrome	1.19e-05	0.000753	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.18e-05	0.00075	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.16e-05	0.000735	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG2—epilepsy syndrome	1.04e-05	0.000657	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.01e-05	0.00064	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP11A1—epilepsy syndrome	1e-05	0.000636	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.96e-06	0.000632	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP2D6—epilepsy syndrome	9.05e-06	0.000574	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADRA2A—epilepsy syndrome	8.62e-06	0.000547	CbGpPWpGaD
Cefotetan—ALB—Metabolism—BCHE—epilepsy syndrome	8.58e-06	0.000544	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	8.5e-06	0.00054	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A1—epilepsy syndrome	8.18e-06	0.000519	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLCB1—epilepsy syndrome	8.1e-06	0.000514	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TH—epilepsy syndrome	8.07e-06	0.000512	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.94e-06	0.000504	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SRC—epilepsy syndrome	7.05e-06	0.000448	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.87e-06	0.000436	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMOX1—epilepsy syndrome	6.73e-06	0.000427	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CAT—epilepsy syndrome	6.64e-06	0.000421	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCB1—epilepsy syndrome	6.46e-06	0.00041	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—epilepsy syndrome	6.01e-06	0.000381	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AGT—epilepsy syndrome	5.27e-06	0.000334	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOE—epilepsy syndrome	5.16e-06	0.000327	CbGpPWpGaD
Cefotetan—ALB—Metabolism—POMC—epilepsy syndrome	4.43e-06	0.000281	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—epilepsy syndrome	4.38e-06	0.000278	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS2—epilepsy syndrome	3.54e-06	0.000224	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—epilepsy syndrome	1.78e-06	0.000113	CbGpPWpGaD
